Dr. Sumeet K. Tewani, MD

Dr. Tewani practices at Rockford Gastroenterology Associates in Rockford, Illinois.

Dr. Tewani's NPI, 1154597284, was assigned on May 8, 2008. Dr. Tewani graduated from Boston University School of Medicine in 2007. Dr. Tewani holds Massachusetts license 242616.

Dr. Tewani's primary practice is Rockford Gastroenterology Associates, at 401 Roxbury Rd, Rockford, IL 61107. The practice phone is (815) 397-7340.

Dr. Tewani's primary practice is Rockford Gastroenterology Associates in Rockford, Illinois. Dr. Tewani is also affiliated with UW Health SwedishAmerican Hospital. The medical group on file is Rockford Gastroenterology Associates. Dmand AI also links Dr. Tewani to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Tewani's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tewani practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tewani's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tewani is licensed in Massachusetts.

CMS data shows 740 Medicare services from Dr. Tewani across 21 procedure codes in 2024, for 369 Medicare patients. Medicare paid $57,205 for them.

CMS counts 369 Medicare patients who saw Dr. Tewani in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tewani's median patient age at 65, with 58% women.

In 2024, Dr. Tewani wrote 941 Medicare Part D claims for 298 patients. 86% of them were for generic drugs. CMS names the drug for 728 of them, across 18 drugs with 11 or more claims each, at $184,546 in total drug cost. In 2023, CMS named 818 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Tewani for performance year 2024, reported as part of a group. Dr. Tewani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 250 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Tewani, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Tewani, published from 2012 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Cholangiopancreatography, Endoscopic Retrograde and Liver Transplantation. Dr. Tewani has published most often in Clin Gastroenterol Hepatol. Dr. Tewani's most frequent co-authors are Gyanprakash A. Ketwaroo, MD, Ram Chuttani, MD and Rakhi N. Kheraj, MD.

CMS Open Payments shows 46 general payments to Dr. Tewani from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Boston Scientific Corporation paid the most, $1,199.

Dr. Tewani graduated from Boston University School of Medicine in 2007.